CorMedix (CRMD) Enterprise Value (2010 - 2025)

CorMedix has disclosed Enterprise Value across 16 years of filings, most recently posting -$155.2 million for Q4 2025.

• Enterprise Value for Q4 2025 came in at -$155.2 million, down 200.27% year-over-year; the trailing twelve-month figure through Dec 2025 was -$155.2 million (down 200.27% YoY), and the FY2025 annual result was -$155.2 million, down 200.27% from the prior year.
• Enterprise Value came in at -$155.2 million for Q4 2025 at CorMedix, down from -$55.7 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$19.8 million in Q2 2023 to a low of -$190.7 million in Q2 2025.
• The 5-year median for Enterprise Value is -$55.7 million (2023), against an average of -$66.3 million.
• Across the five-year window, Enterprise Value tumbled 342.79% in 2021 and jumped 68.91% in 2022, its largest moves.
• CorMedix's Enterprise Value stood at -$53.4 million in 2021, then climbed by 19.04% to -$43.3 million in 2022, then decreased by 1.03% to -$43.7 million in 2023, then dropped by 18.22% to -$51.7 million in 2024, then tumbled by 200.27% to -$155.2 million in 2025.
• The last three Enterprise Value figures came in at -$155.2 million (Q4 2025), -$55.7 million (Q3 2025), and -$190.7 million (Q2 2025), per Business Quant data.